Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Broglio

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
European Journal of Endocrinology|November 27, 2001
Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapyJ A Janssen, F M van der Toorn, L J Hofland, et al.
Journal of Endocrinological Investigation|May 26, 1999
Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humansG Bisi, V Podio, M R Valetto, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
Neuroendocrine and metabolic effects of acute ghrelin administration in human obesityF Tassone, F Broglio, S Destefanis, et al.
Journal of Endocrinological Investigation|May 19, 1998
Low IGF-I levels are often uncoupled with elevated GH levels in catabolic conditionsL Gianotti, F Broglio, G Aimaretti, et al.
Journal of Endocrinological Investigation|April 2, 2009
Plasma total and acylated Ghrelin concentrations in patients with clinical and subclinical thyroid dysfunctionM L Tanda, V Lombardi, M Genovesi, et al.
Clinical Endocrinology|April 24, 2004
The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory stateF Broglio, L Gianotti, S Destefanis, et al.
The Journal of Clinical Endocrinology and Metabolism|March 10, 2001
Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormoneE Arvat, M Maccario, L Di Vito, et al.
European Journal of Pharmacology|October 21, 1999
Cardiac effects of hexarelin in hypopituitary adultsG Bisi, V Podio, M R Valetto, et al.
Journal of Endocrinological Investigation|April 9, 2002
Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: different behavior patterns?G Pittoni, G Gallioi, M Zanello, et al.
Journal of Endocrinological Investigation|October 28, 2004
There are no acute cardiac effects of a single iv dose of human ghrelin in severe growth hormone deficient patientsJ A M J L Janssen, D Poldermans, L J Hofland, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
European Journal of Endocrinology|November 27, 2001
Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapyJ A Janssen, F M van der Toorn, L J Hofland, et al.
Journal of Endocrinological Investigation|May 26, 1999
Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humansG Bisi, V Podio, M R Valetto, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
Neuroendocrine and metabolic effects of acute ghrelin administration in human obesityF Tassone, F Broglio, S Destefanis, et al.
Journal of Endocrinological Investigation|May 19, 1998
Low IGF-I levels are often uncoupled with elevated GH levels in catabolic conditionsL Gianotti, F Broglio, G Aimaretti, et al.
Journal of Endocrinological Investigation|April 2, 2009
Plasma total and acylated Ghrelin concentrations in patients with clinical and subclinical thyroid dysfunctionM L Tanda, V Lombardi, M Genovesi, et al.
Clinical Endocrinology|April 24, 2004
The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory stateF Broglio, L Gianotti, S Destefanis, et al.
The Journal of Clinical Endocrinology and Metabolism|March 10, 2001
Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormoneE Arvat, M Maccario, L Di Vito, et al.
European Journal of Pharmacology|October 21, 1999
Cardiac effects of hexarelin in hypopituitary adultsG Bisi, V Podio, M R Valetto, et al.
Journal of Endocrinological Investigation|April 9, 2002
Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: different behavior patterns?G Pittoni, G Gallioi, M Zanello, et al.
Journal of Endocrinological Investigation|October 28, 2004
There are no acute cardiac effects of a single iv dose of human ghrelin in severe growth hormone deficient patientsJ A M J L Janssen, D Poldermans, L J Hofland, et al.
Pageof 11